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Background: The complex nature of stroke sequelae, the heterogeneity in rehabilitation
pathways, and the lack of validated prediction models of rehabilitation outcomes
challenge stroke rehabilitation quality assessment and clinical research. An integrated
care pathway (ICP), defining a reproducible rehabilitation assessment and process,
may provide a structured frame within investigated outcomes and individual predictors
of response to treatment, including neurophysiological and neurogenetic biomarkers.
Predictors may differ for different interventions, suggesting clues to personalize and
optimize rehabilitation. To date, a large representative Italian cohort study focusing on
individual variability of response to an evidence-based ICP is lacking, and predictors
of individual response to rehabilitation are largely unexplored. This paper describes
a multicenter study protocol to prospectively investigate outcomes and predictors
of response to an evidence-based ICP in a large Italian cohort of stroke survivors
undergoing post-acute inpatient rehabilitation.
Methods: All patients with diagnosis of ischemic or hemorrhagic stroke confirmed
both by clinical and brain imaging evaluation, admitted to four intensive rehabilitation
units (adopting the same stroke rehabilitation ICP) within 30 days from the acute event,
aged 18+, and providing informed consent will be enrolled (expected sample: 270
patients). Measures will be taken at admission (T0), at discharge (T1), and at follow-up 6
months after a stroke (T2), including clinical data, nutritional, functional, neurological, and
neuropsychological measures, electroencephalography and motor evoked potentials,
and analysis of neurogenetic biomarkers.
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Statistics: In addition to classical multivariate logistic regression analysis, advanced
machine learning algorithms will be cross-validated to achieve data-driven prognosis
prediction models.
Discussion: By identifying data-driven prognosis prediction models in stroke
rehabilitation, this study might contribute to the development of patient-oriented therapy
and to optimize rehabilitation outcomes.
Clinical Trial Registration: ClinicalTrials.gov, NCT03968627. https://www.
clinicaltrials.gov/ct2/show/NCT03968627?term=Cecchi&cond=Stroke&draw=2&
rank=2.
Keywords: stroke, rehabilitation, functional recovery, biomarkers, neurophysiology
INTRODUCTION
Stroke is one of the major causes of death and permanent
disability in Western countries, with a growing impact on public
health (1). Thrombolytic therapy represents a great progress
in the treatment of the acute phase of cerebrovascular disease,
but only a minority of patients are eligible and can actually
receive it, and, on the whole, this improvement does not balance
the steady increase of stroke prevalence, both for the greater
longevity of the population and for the lower mortality in
the acute phase. There is wide diversity in stroke severity and
stroke patients (2); of those surviving a stroke, about 65%
present disability and receive rehabilitation. However, deficits in
activity and participation persist in about 30% of the survivors
even after rehabilitation (3), and, to date, very little is known
about long-term functional outcomes (4, 5). Stroke recovery is
heterogeneous in its nature, but the intensity, quality, and timing
of rehabilitation play a central role in the patients’ recovery and
in their reintegration into the community after a stroke (6).
An interdisciplinary, multi-professional intensive rehabilitation
approach tackling not only sensorimotor impairment but
also all the possible associated problems, such as language,
swallowing, sphincter and respiratory impairments as well as
pain, depression, cognitive and/or communication disability, is
highly recommended (6). As to physiotherapy, intensive exercise,
consisting of increased repetitions and aerobic training, seems
to optimize motor and functional outcome in stroke survivors
with post-acute sensorimotor disability (7). However, in Italy, the
implementation of interdisciplinary intensive rehabilitation for
stroke survivors is highly diverse across the country. This is due
to a remarkable interregional and intraregional heterogeneity in
Abbreviations: PSE, post-stroke epilepsy; EEG, electroencephalography; MEP,
motor evoked potential; BDNF, brain-derived neurotrophic factor; FDG,
Fondazione don Carlo Gnocchi; SRRI, scientific rehabilitation and research
institution; ICP, integrated care pathway; IRUs, intensive rehabilitation units; TCT,
Trunk Control Test; MUST: Malnutrition Universal Screening Tool; FMA, Fulg–
Meyer Assessment scale; ADLs, activities of daily living; mBI, modified Barthel
Index; FAC, functional ambulation categories; FAI, Frenchay Activity Index; FWC,
functional walking categories; MoCA, Montreal Cognitive Assessment; OCS,
Oxford Cognitive Screening; TAM, tibialis anterior muscles; CMAP, compound
muscle action potential; TMS, transcranial magnetic stimulation; FA, functional
ability; PMIC, Protocollo di Minima per l’Ictus; MMSE, Mini-Mental State
Examination; MI, motor index.
the rehabilitation pathways, leading to a high risk for inequalities
and suboptimal care (8) as well as to major difficulties in quality
assessment and benchmarking.
Moreover, the complex nature of stroke sequelae requires
several assessment instruments to correctly quantify every
residual symptom and adequately respond to the patients’ needs
during the acute, the post-acute, and the community-living
stroke phase. Standardized assessment tools need to be easy to
use and comprehensive of all the elements necessary to accurately
address the great range of different rehabilitation needs (9).
In this context, the conduction of multicentric studies
and clinical trials might be particularly difficult. Indeed a
standardized, reproducible, and uniform outcome assessment, as
much as a well-defined rehabilitation pathway, is necessary to
investigate the effects of a single intervention during intensive
interdisciplinary rehabilitation as well as for investigating
individual predictors of response to treatment. Predictors may
also differ for different interventions (10), suggesting clues to
personalize rehabilitation and, possibly, improve rehabilitation
outcomes (11). To date, a large representative cohort study
focusing on individual variability of response to a standardized,
evidence-based treatment is lacking (12), and predictive factors of
individual response to treatment are still largely unexplored (13).
The significant inter-individual variability in the outcome
of neurorehabilitation is related to the quality of medical
and rehabilitation treatment in the different phases (14).
However, a complex interaction of baseline health status (age
and previous comorbidity) and physical/cognitive state, stroke
subtype and severity as well as changes in brain structural
architecture (15) is believed to largely influence stroke outcome.
Furthermore, complications in the early-acute phase (16) also
predict outcomes, for instance, post-stroke epilepsy (PSE) that
has a high recurrence rate (30%) 1 year after the acute event (17)
with approximately 50% of patients experiencing a recurrence of
symptoms during a follow-up period of 47 months (18).
Recent studies have also highlighted the importance of
some neurophysiological biomarkers, such as resting state
electroencephalography (EEG) and motor evoked potentials
(MEP), as predictors of motor recovery after a stroke (19).
Finally, a recent line of research is focusing on genetic biomarkers
since some genes, in particular, genetic variations of the brain-
derived neurotrophic factor (BDNF) (20), catechol-O-methyl
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transferase polymorphism (21), and dopamine receptor (22),
have been implicated in stroke recovery and prognosis (23).
Fondazione Don Carlo Gnocchi (FDG) is one of the largest
Italian scientific rehabilitation and research institutions (SRRI)
that have recently developed and implemented an evidence-
based interdisciplinary integrated care pathway (ICP) for post-
acute stroke inpatient rehabilitation (24). After a pilot study
confirming feasibility and suggesting improved outcomes of the
ICP compared to previous practice, this has been adopted in four
intensive rehabilitation units (IRUs) in order to standardize the
outcome definition and the process of care according to national
and international stroke rehabilitation guidelines (6, 25).
This paper describes the background and methods of
a multicenter study protocol to prospectively investigate
outcomes and baseline predictors (including biomarkers) of
function, activity, and participation of patients undergoing
intensive interdisciplinary inpatient rehabilitation after a
stroke. The purpose of the study will be to describe the
influence of several clinical, functional, and psychosocial factors,
neurophysiological patterns, and genetic polymorphisms on the
recovery of body functions, activity, and participation of stroke
survivors undergoing rehabilitation, both in the late-acute phase
(discharged from IRUs) and in the chronic phase (6 months after
a stroke).
MATERIALS AND METHODS
Study Design and Setting
The study is a prospective, longitudinal, and observational cohort
study including four IRUs of the FDG, located in two Italian
regions: Tuscany and Liguria.
All patients admitted to the IRUs of the participating FDG
centers (Florence, Massa, Fivizzano, and La Spezia) with a
history of ischemic or hemorrhagic stroke within 30 days will be
considered for eligibility for this study.
Participants, Recruitment, and Data
Collected
All patients admitted to the participating IRUs and fulfilling the
following inclusion criteria will be assessed and treated according
to the evidence-based stroke ICP and will be considered eligible
for the study.
Inclusion criteria:
• First-ever or recurrent ischemic or hemorrhagic stroke
• Stroke diagnosis confirmed clinically and by brain imaging
• Acute event within 30 days
• Age 18+
• Written informed consent
Exclusion criteria:
• Transitory ischemic attack
• Patients with severe hemorrhagic or ischemic stroke (disorders
of consciousness states and critical clinical care conditions)
addressed to the severe brain injury high-complexity
rehabilitation ward
All eligible patients will be asked to allow anonymous treatment
of their data to participate in the study, and those who will
sign the informed consent will be consecutively enrolled. For
patients who were unable to provide or deny consent and
without an available legal representative, the decision will be
made by a specialist-in-charge who will take responsibility to
act in the patient’s best interest and will inform the patient’s
family and caregivers, according to the Florence university ethical
committee indications.
Based on the average number of stroke patients referred to
the four IRUs involved in the study in the previous years, it
has been planned to enroll 270 patients (90 from Florence,
90 from La Spezia, and 90 from Massa and Fivizzano) in
12 months. The participants’ enrollment will be based on a
purposive sampling technique.
In order to address potential pitfalls related to a reduced
recruitment of patients, specific actions have been considered,
such as the realization of a detailed informed consent for the
patients and offering a follow-up visit together with a full
examination, and free blood exams, the results of which are
directly provided to the medical practitioner.
The multi-professional staff (i.e., physiatrists, neurologists,
physiotherapists, speech therapists, neurophysiologists,
neuropsychologists, occupational therapists, nutritionist,
and nurses) of each center will perform clinical and
neurophysiological assessment by gathering clinical and
neurophysiological data and structural indices of overall brain
damage through brain imaging. At the coordinator center
(Florence, Italy), a SRRI, a nutritional assessment and a blood
draw will also be performed. A blood sample of each participant
will be collected at T0 and T2 for the analysis of genetic markers
that will be performed by the Neurogenetic Laboratory of the
Careggi Teaching Hospital (Florence, Italy).
Measures will be taken at (1) inpatient rehabilitation—
admission (T0), (2) inpatient rehabilitation—discharge (T1), and
(3) follow-up visit 6 months after the acute event (T2). The
timeline of the study is illustrated in Figure 1.
Clinical Evaluation
The clinical assessment will include a dataset of variables grouped
into four categories:
• Clinical and nursing complexity (T0–T1 and T2) including
the presence and severity of comorbidities, assessed through
the Cumulative Illness Rating Scale, and the level of pain,
assessed by the Numeric Rain Scale or the Pain Assessment in
Advanced Dementia. Further markers of complexity include
the presence of medical devices (e.g., tracheostomy, bladder
catheter, nasogastric tube, etc.) and of pressure ulcers,
incontinence, reduced vigilance, delirium, clinical instability,
anemia, dialysis, and depression. Moreover, depression was
assessed through the Hospital Anxiety Depression Scale or
the Stroke Aphasia Depression Questionnaire. Additionally,
dysphagia was assessed by the water swallow test and/or
Functional Oral Intake Scale. Finally, malnutrition screening
(MUST) will be performed at admission and weekly;
the severity of malnutrition (GLIM) (26) will be defined
at admission and discharge. Each patient will receive a
personalized nutritional plan, tailored on their nutritional
assessment, which included the evaluation of nutritional
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FIGURE 1 | Study timeline.
habits, administration route (oral or artificial), and laboratory
exams (blood count, proteins, albumin, transferrin, ferritin,
vitamins, minerals, CRP, TSH and cholesterol).
• Neurological profile including:
• At admission (T0): stroke subtype fulfilling the Oxfordshire
Community Stroke Project and Trial of Org 10172 in acute
stroke treatment for ischemic strokes or intracerebral vs.
subarachnoid for hemorrhagic stroke classifications and
localization and extension of the brain damage as described
by brain imaging, presence of clinical complications
in the acute phase (e.g., late epileptic event, loss of
consciousness, etc.), treatment received during the acute
phase (thrombolytic therapy, neurosurgery, etc.), and
procedural complications if these occurred.
• At discharge (T1) and follow-up (T2): any neurological
event occurring between the T0 and T1 and between T1 and
T2 will be registered (late epileptic event, recurrence, etc.).
Overall neurological impairment will be assessed by the National
Institutes of Health Stroke Scale that will be reassessed at each
visit time.
• Functional evaluation including measures of impairment,
disability, and participation.
• Sensorimotor impairment will be assessed at all-time points
by the trunk control test (TCT), Fulg–Meyer Assessment
Scale (FMA), and modified Ashworth Scale.
• Disability will be measured at all time points by the
modified Barthel Index (mBI), the modified Rankin scale,
the Scale of Disability in Communication (SDC) and the
Functional Ambulation Categories (FAC), and the Short
Physical Performance Battery.
Participation will be assessed at T0 (anamnestic pre-stroke)
and T2 (6 months from stroke) by the Frenchay Activity
Index (FAI) and the FunctionalWalking Categories (FWC).
• Neuropsychological evaluation at T0 will include two
tests of global cognitive screening, the Montreal Cognitive
Assessment (MoCA) and the Oxford Cognitive Screen
(OCS), followed by a minimal neuropsychological
battery as detailed in Table 1. Two parallel versions
and a third parallel version of the MoCA test will be
administered, respectively, at T1 and at T2 as well as the
same minimal neuropsychological battery administered
at baseline.
All assessment tools are shown in Table 1, and their




An EEG of 20min of wakefulness will be performed using
Galileo NT (EBNEURO) with 32 channels through an
EEG prewired Headcap19 recording electrode, one ground
electrode, and a reference positioned according to the 10–20
International System. The signal will be sampled at 128Hz,
with sensitivity set at 7 uV/mm, and then filtered (1.6–30Hz).
The examination will be carried out on a chair or on a
wheelchair on the basis of the patient’s clinical conditions.
During the 20-min recording period, patient reactivity will
be assessed through active or passive eyes’ opening and
closing depending on the degree of patient collaboration.
Hyperventilation will not be performed as most patients
have contraindications arising from age and cardiac and
respiratory problems associated with cerebrovascular insult.
Electroencephalographic abnormalities will be classified
according to the American Clinical Neurophysiology Society’s
standardized critical care EEG terminology (27, 28). In
particular, epileptiform abnormalities will be classified as follows:
(1) interictal epileptiform activity, (2) periodic discharges, and
(3) electrographic seizures.
Frontiers in Neurology | www.frontiersin.org 4 April 2021 | Volume 12 | Article 632672
Hakiki et al. Markers of Post-stroke Rehabilitation Response
TABLE 1 | Administrated scales and evaluations.







Cumulative Illness Rating Scale X X X
Markers of complexity X X X
Body mass index X
Functional Oral Intake Scale/water swallow test X
Numeric Rain Scale/pain assessment in advanced
dementia
X X X
Hospital Anxiety Depression Scale X
Stroke Aphasia Depression Questionnaire X
Presence of transitional adverse event X X
Neurological profile National Institutes of Health Stroke Scale X X X
Trial of Org 10172 in Acute Stroke Treatment X
Oxfordshire Community Stroke Project X
Stroke localization and extension early clinical
complications, thrombolysis/fibrinolysis
X
Presence of new neurological events X X
Functional evaluation Trunk Control Test X X X
Fulg–Meyer Assessment Scale X X X
Short Physical Performance Battery X X X
Modified Barthel Index X X X
Modified Rankin scale X X X X
Scale of disability in communication X X X
Functional ambulation categories X X X
Medical Research Council Scale X X X
Activity of daily living disabilities: Frenchay Activity
Index
X X





Montreal Cognitive Assessment X X X
Oxford Cognitive Screening X X
Babcock story recall test X X
Digit span forward and backward X X
Symbol Digit Modalities Test X X
Stroop Test X X
Token and naming subtests of the Aachen Aphasia
Test
X X
Fluff test X X




Motor evoked potential X X
Genetic markers Brain-derived neurotrophic factor X X
Reliability and quality control among the repeated
measurements in the two centers (Florence and La
Spezia) will be guaranteed by the use of the same
instrumentation, the same EEG technicians performing the
examination, and the same experimenters conducting the
signal classification.
Motor Evoked Potentials
Transcranial magnetic stimulation (TMS) will be performed only
in the center of Florence according to the standard criteria of the
International Federation of Clinical Neurophysiology (29). Five
consecutive responses in a 100-ms post-stimulus period will be
analyzed. The size of MEP induced by TMS will be expressed
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as MEP/CMAP amplitude ratio, where MEP is the average of
5 consecutive peak-to-peak (most negative to the most positive
peak) responses amplitude and CMAP is the Compound Muscle
Action Potential of target muscle, evoked by supramaximal
electrical peripheral nerve stimulation (ulnar nerve at the wrist
for Abductor Digiti Minimi, ADM, Peroneal Nerve at Knee for
Tibiali anterior, TA). The procedure will be performed for both
upper limbs in all subjects.
The exclusion criteria are (1) Medical Research Council grade
≥4 (patients were able to perform a movement in all amplitudes
even against minimal resistance by the examiner), (2) cognitive
deficit hampering the patient’s collaboration, (3) presence of
a pacemaker, and (4) presence of physical limitations (e.g.,
bandages or plasters) that prevent the evaluation of peripheral
muscular response through the CMAP.
The examination will be conducted with the Medelec
Synergy electromyograph (Natus Europe) associated with the
MagVenture MagPro Compact magnetic stimulator equipped
with a circular coil.
Disposable surface electrodes (Bionen Florence, Italy) will be
placed on the muscle under examination.
Once the motor response of supramaximal amplitude will
be obtained, the magnetic stimulus will be delivered. A circular
coil will be used to map the area of interest corresponding
to the target muscles studied: for the TA, given the cortical
representation, the coil will be positioned slightly ipsilateral to
the side under examination in correspondence to Cz, while
for the ADM, the coil will be positioned contralaterally taking
Cz as reference. By asking the patient to perform a minimal
contraction, at least five responses will be obtained and averaged
in order to obtain reliable measures. A sixth stimulus will be
delivered in a resting situation for interside comparison in those
cases where the patient will be unable to activate the affected side.
A stimulus will be provided at the paraspinal level only in the
assessment of the upper limbs due to the increased accessibility
of the stimulation site.
The MEP will be classified as follows:
• Normal
• Pathological if the MEP will be recordable but not within the
reference values for amplitude and/or absolute latencies
• Absent if no response higher than 50 µV could be obtained
after 5 stimuli at 100% intensity
The study foresees a further evaluation of the neurophysiological
parameters during follow-up (T2), which corresponds to 6
months after a stroke.
Analysis of Genetic Markers (T0–T2)
For the subgroup of patients in the Florence Intensive
Rehabilitation Unit who will sign a further dedicated informed
consent, a blood sample, along with the routine blood draw at
T0 and T2, will be frozen and sent to the University Hospital
Neurogenetic Lab. The study will focus on the polymorphism
analysis of BDNF (T0); furthermore, the epigenetic analysis
of the BDNF will be carried out by the evaluation of the
methylation levels of the BDNF gene promoter. The DNA of
the subjects will be extracted from peripheral blood using an
automatic standardized method (QIAcube, QIAGEN). BDNF
Val66Met polymorphism analysis (rs6265) will be performed by
PCR amplification of the gene region containing the variant using
the following primers—forward: 5′-ACT CTG GAG AGC GTG
AAT GG-3′, reverse: 5′-TCCAGG GTG ATG CTC AGT AGT-3′.
Subsequently, high-resolution melting analysis will be carried
out to identify individual variations of bases present in the
amplified region. The melting curve generated by the analysis
will be different for each genotype of polymorphism. Three
control genotypes previously identified through sequencing will
be used as references (310 ABI PRISM Genetic Analyzer, Applied
Biosystem). If the promoter of the gene is found to be hyper-
methylated, there will be a suppression of protein expression
levels, resulting in a reduction in protein function. The epigenetic
changes will be evaluated at two different times, at the patient’s
entry (T0) and at follow-up (T2), to study the possible influence
of the treatment on the methylation levels of the BDNF gene.
The genetic polymorphism data will be compared to
sex- and age-matched controls of the DNA bank of the
Neurogenetic Laboratory.
Rehabilitation
The rehabilitation intervention is defined in an ICP based on
the American Heart Association/American Stroke Association
guidelines and on the ICF model (6, 24), and detailed description
and discussion can be found elsewhere (24). Synthetically,
the standardized rehabilitation assessment and process of care
provide, according to the national requirements, at least 3 h
per day of specific rehabilitation including physiotherapy,
neuropsychological therapy, speech and dysphagia therapy, and
occupational therapy, in addition to the assessment and training
in the use of aids, based on systematic screening at admission,
systematic weekly team revisions of individual rehabilitation
plan, and emerging needs any time during the rehabilitation
stay. When indicated, psychological support to patient and or
family is also provided. Physiotherapy may also include robotic
rehabilitation of the upper limb according to the individual
rehabilitation plan defined by the interdisciplinary team. Specific
rehabilitative interventions are summarized in Figure 2.
Outcome Measures
The primary outcome is improvement of functional ability that
will be evaluated based on the change in the activities of daily
living as assessed by the mBI, between T0 and T1, and between
T0 and T2.
Secondary outcomes include cognitive recovery that will be
evaluated by comparing the performances in the parallel versions
of the MoCA, administered at all time points, and recovery
of participation at 6 months, compared to pre-stroke data,
according to the FAI and the FWC.
Other selected rehabilitation outcomes will include length
of stay, adverse outcomes (post-stroke epilepsy, deaths, or
discharge to acute care hospital), functional and clinical
indicators recorded at admission and discharge for changes
in sensory–motor impairment (FMA), SDC, TCT, and
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FIGURE 2 | Rehabilitation treatment.
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ambulation (FAC). Changes in markers of complexity will
also be considered. Follow-up outcomes will include all of
the above, EEG and MEP and BDNF epigenetics, intended
as biomarkers of neuroplasticity. All demographic, clinical,
functional, neuropsychological, and neurogenetic baseline
variables will be analyzed as possible predictors/biomarkers of
rehabilitation outcomes.
Data Collection, Management, and
Analysis
Data collection will be carried anonymously on REDCap, an
online-based software for the design of databases. This will
allow one to control the quality in data collection to reduce
the number of missing data and then achieve a robust basis for
the analyses.
Data will be secured by private credentials, saving the
correspondences between names and identification codes on a
separate document that will be destroyed at the end of the study.
Statistical analyses will be performed using SPSS 26.0 software
(IBM SPSS, Chicago, Illinois, USA). Descriptive statistics of
variables belonging to the four clinical assessment categories
(clinical and nursing complexity, neurological profile, functional
evaluation, and neurocognitive profile, neurophysiological
parameters, and methylation levels of the BDNF gene) will be
provided for each time point. The statistics will include absolute
counts and relative frequencies for categorical and dichotomous
variables, while mean and standard deviation or median and
interquartile range will be according to the parametric or non-
parametric distribution of the investigated numeric variables.
Violation of the parametric assumption will be ascertained using
the Shapiro–Wilk test.
Variables recorded at two time points will be compared using
paired t-test or a Wilcoxon signed rank test as appropriate for
the normality of the data; for numeric scales, the McNemar test
for paired categorical or dichotomous data will be used instead.
For those variables evaluated at all time points, differences over
time will be ascertained using a repeated-measures ANOVA or
Friedman test for continuous variables and Cochran’s Q test for
dichotomous variables, and Bonferroni and Sheffé corrections
will be applied to multiple comparisons. In all the above-
mentioned analyses, p value <0.05 will be considered as level of
statistical significance.
In the second step of the analysis, four classes will be identified
based on the mBI score: functional ability (FA) class 1: mBI <25,
corresponding to a severe impairment; FA class 2: mBI between
25 and 50, corresponding to a moderate impairment; FA class 3:
mBI between 50 and 75, corresponding to a mild impairment;
and FA Class 4: mBI >75, corresponding to no impairment.
Patients having missing values for the mBI will be excluded from
further analyses.
Two groups will be then created based upon the FA class
assessed at different time points (“improved FA” and “not
improved FA”). Those variables identified through univariate
analysis as recovery predictors will be grouped in five
categories: clinical/nursing complexity (including anagraphical
data), neurological profile, functional factors, cognitive factors,
neurophysiological parameters, and genetic profile. For each
category, a multiple logistic regression analysis will be conducted
to investigate whether there is a relationship with improved
FA. The analysis will be then repeated, including variables from
different categories that showed a significant association with the
presence of a higher FA class at discharge or follow-up.
In addition to the classical multivariate logistic regression
analysis, advanced machine learning algorithms will be cross-
validated to achieve data-driven prognosis prediction models.
Classical solutions such as linear and logistic regression will
be compared with solutions based on support vector machines,
random forests, or multi-layer perceptrons and also with
“deep” artificial neural networks (convolutional neural networks,
recurrent neural networks, and ensemble learning solutions).
The performances of different algorithms in predicting
recovery outcomes will be compared in terms of accuracy, F1
score, root mean square error, and determination coefficient. The
effect of hyperparameter tuning and automatic features selection
strategies will also be tested by nested cross-validation, with
the final aim to quantify the solution generalization capability
when applied to new patients who were not included in model
definition and training.
DISCUSSION
The past decade has seen great progress in the treatment
of cerebrovascular diseases in the acute phase. However,
stroke remains a catastrophic event of huge public health
consequence, causing five million deaths each year and an
increasing number of persons surviving with chronic disability
worldwide (30). Recovery from stroke is a complex process that
is achieved through a combination of spontaneous learning-
dependent steps, including restoration (of the functionality
of neural damaged tissue), substitution (of partly spared
neural pathways to relearn lost functions), and compensation
(leading to improve the disparity between impaired skills and
the environmental requirements). Rehabilitation is recognized
to effectively reduce post-stroke disability burden (31), but
stroke rehabilitation presents specific challenges for research,
especially in the definition of outcome assessment and in the
customization of rehabilitation strategies. To allow the evaluation
and comparison of rehabilitation outcomes on large populations
of stroke patients (32) and to investigate predictors/biomarkers
of rehabilitation outcomes, it is mandatory that evidence-
based rehabilitation assessment and care processes are clearly
defined and comparable, yet systems of care, approaches to
stroke rehabilitation delivery, and outcome assessment as well
as resources for stroke care and rehabilitation are still extremely
variable across geographic regions worldwide (33).
In Italy, stroke rehabilitation recommendations make general
reference to national and international guidelines (34), but
their operational definition to protocols and pathways is
very heterogeneous and significantly affected by the different
standards applied at the regional and even the local level,
creating a high risk for suboptimal care (8). To date, there is no
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standard quality assessment for the benchmarking of different
rehabilitation facilities and strategies (9).
Furthermore, the customization of rehabilitation treatment
according to individual predictors and relatively novel
biomarkers of rehabilitation outcome would provide a ratio
attempting in the optimization of the rehabilitation outcomes.
However, this research is strongly limited by the lack of
standardization of the applied rehabilitation pathway and of
adequately validated prediction models.
Indeed optimization of rehabilitation strategies is yet
largely limited by the restricted knowledge existing on
biomarkers of rehabilitation outcome: thus, besides the
clinical–functional component, the present study will also
investigate neurophysiological and genetic parameters as
possible biomarkers of functional outcome.
EEG, in addition to the identification of epileptic
abnormalities as possible predictive index of PSE occurrence,
could allow data for quantitative analysis (connettoma) for the
eventual prediction of PSE onset. PSE has been identified as a
significant clinical issue in stroke survivors, with an incidence
rate of around 7% (35). It has also been associated with a poor
prognosis and increased mortality in post-stroke survivors (36).
As to motor recovery, it will also be verified whether
and how the combination of the collected neurophysiological
measures (EEG and MEP) could contribute to motor prognosis.
Recent studies have emphasized the importance of some
neurophysiological markers as possible predictors of motor
recovery after a stroke (19). In particular, an ipsilesional loss of
power in the alpha frequency band and an increase in the delta
frequency band in the EEG detected within 2 weeks of stroke are
linked to a poor outcome (37), and quantitative EEG biomarkers
might predict motor recovery within 3 weeks of stroke symptom
onset (38). As to TMS that evaluate the integrity of human motor
pathways (39), corticospinal excitability measured by TMS has
been identified as a possible biomarker of upper limb motor
function in patients with stroke (11, 19). MEP of the extensor
digitorum communis amplitudes within the first 4 weeks after
stroke also seems to be associated with a higher score in the FMA-
UE26 (40). The assessment of residual central and peripheral
neural motor circuitry complementing TMS analysis with motor
nerve conduction exams might increase the prognostic accuracy
for motor and functional outcome in patients with stroke.
As for neurogenetic potential biomarkers, we focused on the
epigenetics of the single-nucleotide polymorphism of the BDNF
gene that has been reported to impact neuroplasticity and motor
learning in humans. BDNF is known to play a pivotal role in
synaptic plasticity and enhanced neurogenesis in adults (41),
and BDNF polymorphism is also known to be associated with
post-stroke motor learning in adults. Interestingly, the effect
of BDNF polymorphism on motor learning is likely influenced
by the extent to which motor practice engages neuroplasticity
and therefore by the rehabilitative approach. The Met allele
carriers were shown to perform worse compared with Val/Val
phenotype (42) and showed a reduction in the magnitude of
motor improvement with therapy (43). Kim et al. (44) also
reported that BDNF Val66Met polymorphism affected the degree
of corticospinal degeneration. More recently, Oh et al. (45)
showed that the degree of swallowing recovery after a stroke
could be influenced by a polymorphism in BDNF rs6265.
An increasing number of studies focus on the use of
demographic, clinical, and neurological variables to predict
functional outcomes after a stroke, and several studies use
automatic tools to make predictions rather than simply providing
multivariable regression equations. However, the use of these
tools to predict discharge outcomes (46, 47) could represent a risk
in clinical practice of justifying an early discharge once a specific
level of function has been reached. Therefore, the objectives of
the use of prediction tools need to be carefully addressed as
part of their implementation to ensure that they are used to aid
rehabilitation planning and goal setting rather than as a means of
restricting access to services (48). Concretely speaking, previous
research aimed at the automatic prediction of the probability
of clinical binary outcomes, such as independent walking (46),
performing a percutaneous endoscopic gastrostomy, and the
probability of achieving at least one specific clinical score for
independence (47) or upper limb activity (49). Other crucial
aspects to be discussed from the existing predictive models in
stroke populations is the overlooked necessity of an external
validation of computational solutions and the exploration of
predictors independently on the scales in use. Concerning the
former point, the so-called overfitting of methods is a common
issue of machine learning methods applied to clinical trials.
Indeed the identification of predictive factors for a better
rehabilitation outcome after stroke should be targeted to a
specific population, but at the same time a performant predictive
model should be able to generalize and extend its predictive
power to new data (47). For what concerns the choice of predictor
variables, many studies report as limitations a constrained choice
of the variables used as predictors, resulting in an omission of
potentially more relevant features for the selected outcome (50).
The extensive assessment provided in this prospective study will
allow a more detailed description of the population before and
after the rehabilitation treatment and the possibility to exploit
an automatically or statistically driven feature selection for the
predictive models.
In the present work, the outcome measures have been chosen
to reflect, as realistically as possible, the functions, activity, and
participation of the patient, and the possible predictors identified
will be used to better tailor the rehabilitation pathway for each
individual patient. The study also aims to identify clinical and
instrumental markers predicting different outcome categories in
different time points (at discharge and at 6 months after the
acute event), which may be highly relevant both to patients
and clinicians. Thus, a comprehensive protocol for the stroke
population will be generated and tested to be potentially applied
in the clinical practice of many centers. The applicability of
this protocol is also supported by the consideration that, with
the exception of the neurogenetic assessment, all the clinical
and instrumental variables selected in this study are easily
exportable to other clinical realities because of their low cost and
high feasibility.
In conclusion, the present study plans to identify reliable
predictive factors of specific functional, cognitive, and
participation domains in the late-acute and the chronic
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phase after stroke by exploring the complex interaction between
clinical–functional variables, genetic markers, and changes
in brain structural architecture using neurophysiological
evaluations. In addition to the classical multivariate logistic
regression analysis, advanced machine learning algorithms will
be cross-validated to achieve data-driven prognosis prediction
models. The final aim of these models is to develop patient-
oriented therapy, addressing personalized treatment plans that
could be recommended and translated in routine clinical practice
for optimizing care management.
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